← Browse by Condition
Medical Condition

short stature homeobox gene mutation

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT07221851 Phase 3
Recruiting

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

Enrollment
186 pts
Location
United States
Sponsor
Ascendis Pharma A/S
View Trial →